ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 995

In Rheumatoid Arthritis Only a Few Expanded T-Cell Clones Dominate in Joint Inflammation: A Study in Seven RA Patients Undergoing Paired Synovial Tissue Biopsies in Multiple Joints

Anne Musters1, Paul L. Klarenbeek1,2, Marieke E. Doorenspleet1,2, Rebecca E.E. Esveldt1,2, Barbera D.C. van Schaik3, Sander W. Tas1,2, Antoine H.C. van Kampen3, Frank Baas4 and Niek de Vries1,2, 1Dept. of Clinical Immunology & Rheumatology, Amsterdam Rheumatology and immunology Center | Academic Medical Center/University of Amsterdam, Amsterdam, Netherlands, 2Dept. of Experimental Immunology, Academic Medical Center/University of Amsterdam, Amsterdam, Netherlands, 3Bioinformatics Laboratory, Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Academic Medical Center/University of Amsterdam, Amsterdam, Netherlands, 4Dept. of Genome Analysis, Academic Medical Center/University of Amsterdam, Amsterdam, Netherlands

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Arthroscopy, Rheumatoid arthritis (RA), synovial cells, synovial fluid and synovium, T cells

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 8, 2015

Title: T cell Biology and Targets in Autoimmune Disease I

Session Type: ACR Concurrent Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose: Previously we found a strong enrichment of highly expanded
T-cell clones in rheumatoid arthritis (RA) synovial tissue of inflamed joints. To
gain more insight into the potential role of these expanded clones in the
inflammatory polyarthritis in this disease, we studied the distribution of these
T-cell clones: Are they present only locally in the inflamed synovium? If not,
to what extent are they also present in synovial biopsies taken from a different
location in the same joint, or from a different joint?

Methods: In
seven RA-patients we simultaneously obtained synovial tissue (ST) biopsies from
two inflamed joints (N=7; ankle or knee) via mini-arthroscopy together with paired
peripheral blood (PB; N=7) and synovial fluid samples (SF; N=5). ST biopsies
were obtained from ankle (N=1) or from the infrapatellar region of the knee
(N=6). In 6 patients we took
additional independent suprapatellar (SP) biopsies within the same knee joint. Samples
were processed for RNA-based next generation sequencing (NGS). T-cell clones
were identified by their unique T-cell receptor β-chain sequence, the degree
of expansion being expressed as a percentage of the total number of NGS reads. (Paired)
student T-tests or Wilcoxon (matched-pair) signed rank test were performed
where applicable.

Results: We
identified 904,631 clones in 6,955,333 TCR-sequences. Of the top-25 most
expanded clones in ST only a limited number were retrieved as top-25 clone in
SF (18%; SEM 6.3) and in PB (24%,
SEM 5.1). In contrast, considerable overlap was seen if we analyzed cellular
infiltrate in synovial tissue biopsies from different regions of the same joint:
49% (SEM 6.2) of the top-25 ST clones were also retrieved as a top-25 clone in
the suprapatellar biopsy of the same joint (p<0.005).
When comparing different joints in the same patient, we noted that 52% (SEM 5.0) of the top-25 clones from the 1st
joint were also amongst the top-25 clones in the 2nd joint (see
figure 1).

Conclusion: Synovial
fluid T-cells do not fully reflect the repertoire of dominant clones in the
synovial tissue. Synovial tissue biopsies from different locations within the
same joint or taken from different joints show substantial overlap of the most
dominant T-cell clones in patients with active RA. Given the evidence pointing
to T-cell involvement in the pathogenesis of RA this suggests that in
individual patients a limited number of T-cell clones dominate the adaptive
immune response. Detailed cellular characterization
of these clones seems warranted, and may help to devise more selective
strategies for therapeutic targeting.

Figure 1 |
percentage of overlapping top 25 TCRb clones. ST= synovial tissue; L= left; R=
right; SP; suprapatellar region; SF= synovial fluid; PB= peripheral blood. ** =
p<0.005; ns= not significant.


Disclosure: A. Musters, None; P. L. Klarenbeek, None; M. E. Doorenspleet, Patent on “Method for diagnosing IgG4 related diseases”, application number PCT/ EP2013/070384, publication number WO/2014/049177, 9; R. E. E. Esveldt, BTCURE, 2; B. D. C. van Schaik, None; S. W. Tas, None; A. H. C. van Kampen, None; F. Baas, None; N. de Vries, None.

To cite this abstract in AMA style:

Musters A, Klarenbeek PL, Doorenspleet ME, Esveldt REE, van Schaik BDC, Tas SW, van Kampen AHC, Baas F, de Vries N. In Rheumatoid Arthritis Only a Few Expanded T-Cell Clones Dominate in Joint Inflammation: A Study in Seven RA Patients Undergoing Paired Synovial Tissue Biopsies in Multiple Joints [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/in-rheumatoid-arthritis-only-a-few-expanded-t-cell-clones-dominate-in-joint-inflammation-a-study-in-seven-ra-patients-undergoing-paired-synovial-tissue-biopsies-in-multiple-joints/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/in-rheumatoid-arthritis-only-a-few-expanded-t-cell-clones-dominate-in-joint-inflammation-a-study-in-seven-ra-patients-undergoing-paired-synovial-tissue-biopsies-in-multiple-joints/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology